Does IRINOTECAN Cause Interstitial lung disease? 337 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 337 reports of Interstitial lung disease have been filed in association with IRINOTECAN (Irinotecan Hydrochloride). This represents 1.2% of all adverse event reports for IRINOTECAN.
337
Reports of Interstitial lung disease with IRINOTECAN
1.2%
of all IRINOTECAN reports
110
Deaths
173
Hospitalizations
How Dangerous Is Interstitial lung disease From IRINOTECAN?
Of the 337 reports, 110 (32.6%) resulted in death, 173 (51.3%) required hospitalization, and 46 (13.6%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRINOTECAN. However, 337 reports have been filed with the FAERS database.
What Other Side Effects Does IRINOTECAN Cause?
Diarrhoea (4,157)
Neutropenia (2,533)
Nausea (2,374)
Disease progression (2,018)
Off label use (2,018)
Vomiting (1,944)
Fatigue (1,515)
Febrile neutropenia (1,357)
Anaemia (1,231)
Thrombocytopenia (1,214)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which IRINOTECAN Alternatives Have Lower Interstitial lung disease Risk?
IRINOTECAN vs IRON
IRINOTECAN vs IRON DEXTRAN
IRINOTECAN vs IRON ISOMALTOSIDE 1000
IRINOTECAN vs IRON POLYMALTOSE
IRINOTECAN vs IRON SUCROSE